Product category:
HTS and combinatorial chemistry equipment
News Release from: Cellomics Europe | Subject: ArrayScan reader v4.0
Edited by the Laboratorytalk Editorial
Team on 18 July 2002
New HCS reader at the forefront of drug
discovery
Allows users to extract vital data on the relative distribution and activity of cellular constituents combined with morphometric measurements in fixed samples
Cellomics Europe has announced the launch of an enhanced and improved version of its ArrayScan high content screening (HCS) reader The ArrayScan HCS reader version 4.0 provides a complete, automated solution for cell-based screening, allowing users to extract vital data on the relative distribution and activity of cellular constituents combined with morphometric measurements in fixed samples
This article was originally published on Laboratorytalk on 11 Oct 2001 at 8.00am (UK)
Related stories
Automation for cell-based drug discovery
The ArrayScan HCS system from Cellomics is a proprietary drug discovery instrument that performs automated measurement and analysis of spatial and temporal events in cells
Hallmark indicators of drug toxicity
The multiparameter Cytotoxicity 1 assay is the latest in Cellomics's series of HitKits, to quantify multiple hallmark indicators of drug toxicity in cells
Building upon the large installed base of previous generation ArrayScan HCS readers, version 4.0 incorporates a new, completely automated optical bench, expanded filter combinations, additional objective options, and optimised computer hardware and software.
The result is significant enhancements in key performance criteria including flexibility, ease of use, and speed.
The new system, developed after consultation with Cellomics HCS customer base, provides a unique solution that allows the expansion of high content screening with more users per instrument, carrying out a wider variety of multiplexed assays, in a much shorter time frame.
A new 'protocol assignment' feature allows multiple scientists to carry out different HCS assays in the same unattended run.
Expanded six-colour capability enables wider reagent selection to be applied to each multi-parameter assay.
Speed enhancements have resulted in a 40% reduction in plate scan times.
Cellomics continues to provide researchers with innovative tools to reduce manual operations, boost productivity, and increase reproducibility of cell-based assays.
• Cellomics Europe: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

